Provided by Tiger Fintech (Singapore) Pte. Ltd.

TransMedics Group, Inc.

68.53
+4.186.50%
Post-market: 68.00-0.5300-0.77%19:45 EDT
Volume:908.53K
Turnover:61.76M
Market Cap:2.31B
PE:67.85
High:68.79
Open:65.72
Low:65.26
Close:64.35
Loading ...

TransMedics Group Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
11 Mar

Stock Track | TransMedics Group Soars 5.22% on Upbeat Q4 Results and Positive Outlook

Stock Track
·
05 Mar

TransMedics Group (NasdaqGM:TMDX) Sees 3% Price Rise As Revenue Hits US$122M In Strong Q4 2024

Simply Wall St.
·
05 Mar

Piper Sandler Sticks to Its Buy Rating for TransMedics Group (TMDX)

TIPRANKS
·
04 Mar

Morgan Stanley Reaffirms Their Hold Rating on TransMedics Group (TMDX)

TIPRANKS
·
03 Mar

Transmedics Group Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Mar

Is TransMedics Group, Inc. (TMDX) the Worst Performing Mid Cap Stock to Buy According to Analysts?

Insider Monkey
·
01 Mar

TransMedics Stock Rises as Q4 Earnings & Revenues Beat Estimates

Zacks
·
01 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Recursion Pharmaceuticals, DoubleVerify Holdings, Praxis Precision Medicines

Reuters
·
28 Feb

Stock Track | TransMedics Group Soars 6.77% in Pre-Market on Stellar Q4 Results, Robust 2025 Outlook

Stock Track
·
28 Feb

BUZZ-TransMedics climbs on Q4 revenue beat

Reuters
·
28 Feb

Transmedics Group Shares up About 5% Premarket After Q4 Results

THOMSON REUTERS
·
28 Feb

Stock Track | TransMedics Group Stock Soars 6.07% in Pre-Market on Strong Q4 Results, Robust 2025 Outlook

Stock Track
·
28 Feb

TransMedics Group Inc (TMDX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
28 Feb

Stock Track | TransMedics Group Soars 8.08% After-Hours on Stellar Q4 Results and Upbeat 2025 Outlook

Stock Track
·
28 Feb

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Cardiff Oncology (CRDF)

TIPRANKS
·
28 Feb